"We're working very closely with the company," health minister told BBC TV
The data will likely increase confidence that more vaccines will work and that the world may soon find a way to get the coronavirus under control
The vaccine is more stable than expected at temperatures that ordinary refrigerators can provide
The spread of Covid-19 has been contained in most parts of our country
BioNTech co-founder Uğur Şahin told BBC One's The Andrew Marr Show on Sunday: "this winter will be hard and the vaccine will not have a big impact on the infection numbers
A successful inoculation could be a key factor in overcoming reluctance to take pandemic vaccines that have been developed at top speed.
The Russian 'Sputnik V' vaccine for Covid-19 has arrived in India for human clinical trial
Pfizer's potential vaccine is likely to be a two-dose course of treatment
The Maharashtra government has said that the the second wave of coronavirus is expected in the state in January-February based on what is happening in Europe
Anthony Fauci on Wednesday said it would be challenging to distribute vaccines that use messenger RNA based technology in developing countries
Under the EU deal, 27 European countries could buy 200 million doses, and have an option to purchase another 100 million
CEO Albert Bourla authorized the sale of the shares on Aug. 19, provided the stock was at least at a certain price, as part of a predetermined plan, the company said
The tech-skewed Nasdaq advanced 1.5%, while technology mega-caps including Netflix Inc, Amazon.com Inc and Facebook Inc, the so-called stay-at-home winners, also gained between 1% and 2%.
Under the EU deal, 27 European countries could buy 200 million doses, and have an option to purchase another 100 million.
Hopes of the world soon getting an effective vaccine were raised on Monday
The WHO says if any vaccine has more than 50 per cent efficacy, it is good enough
Important scientific announcements are usually made through peer-reviewed medical research papers, not company press releases
The European Commission will sign a deal to secure up to 300 million doses of the experimental coronavirus vaccine developed by BioNTech and Pfizer
Shares in video conferencing network Zoom fell 4% on Tuesday after plunging about 17% a day earlier
Pfizer is committed to ensure the availability of its Covid vaccine for use by governments across the world.